"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer.
Gynecol. Oncol., Mar;116(3):370-3 (2010)
A microRNA expression signature for cervical cancer prognosis.
Cancer Res., Feb;70(4):1441-8 (2010)
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
J. Clin. Oncol., Apr;28(12):2108-13 (2010)
The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy.
Cancer., Mar;117(5):948-56 (2011)
Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.
Clin. Cancer Res., Mar;18(5):1464-71 (2012)
Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
Cancer., Aug;115(15):3548-54 (2009)
Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
Int. J. Radiat. Oncol. Biol. Phys., Jul;77(4):1085-91 (2010)
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
Gynecol. Oncol., Mar;116(3):438-41 (2010)
Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.
Gynecol. Oncol., Mar;116(3):539-43 (2010)
Long-term assessment of bladder and bowel dysfunction after radical hysterectomy.
Gynecol. Oncol., Jul;114(1):75-9 (2009)
ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
J. Clin. Oncol., Jul;27(19):3091-6 (2009)
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
Gynecol. Oncol., Jan;112(1):104-9 (2009)
Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers.
Clin. Cancer Res., May;14(10):3089-97 (2008)
Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer.
Int J Med Sci., 5(3):133-42 (2008)
Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer.
Radiat Med., Nov;25(9):439-45 (2007)
CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
Cancer Res., Dec;67(23):11202-8 (2007)
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
J. Clin. Oncol., May;25(15):2042-8 (2007)
External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
Gynecol. Oncol., Jul;106(1):215-20 (2007)
Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
Int. J. Radiat. Oncol. Biol. Phys., Feb;67(2):480-4 (2007)
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.
Mod. Pathol., Oct;19(10):1333-8 (2006)